Third Harmonic Bio, Inc. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q1 2025.

Location
San Francisco, CA
Fiscal year end
31 December
Latest financial report
08 May 2025

Quick Takeaways

  • Third Harmonic Bio, Inc. financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q1 2025.
  • Headline metric: Return On Equity -20%.

What Changed

  • Return On Equity YoY change: <span class="text-green-600">+84%</span>.
  • Most recent SEC facts end date: 31 Mar 2025.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Official SEC Source

Based on latest 10-Q/10-K

Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.

See Original Filing

Latest SEC snapshot (2025-03-31) highlights Return On Equity -19.9%, Return On Assets -19.4%, and Current Ratio 54.1x.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

18.3/100

Weak Confidence medium

Return On Equity

-20%

Metric score 0.0/100

Return On Assets

-19%

Metric score 0.0/100

Financial Health

Current Ratio
54.1x
Debt to Equity
0.03x

Strengths

Debt-to-equity

Watchpoints

Return On Equity, Return On Assets, and Current Ratio

Key metrics snapshot

Return On Equity

-20%

YoY: +84%

Industry median: -43% (n=675)

View history

Return On Assets

-19%

YoY: +84%

Industry median: -47% (n=673)

View history

Current Ratio

54.1x

YoY: -18%

Industry median: 3.39x (n=667)

View history

Debt-to-equity

0.03x

YoY: +6%

Industry median: 0.26x (n=530)

View history

NetIncomeLoss YoY

-81%

YoY:

Industry median: -0.93% (n=641)

View history

Profitability

Metric Latest value YoY change
Return On Equity -20% +84%
Return On Assets -19% +84%

Financial Health

Metric Latest value YoY change
Current Ratio 54.1x -18%
Debt-to-equity 0.03x +6%

Growth

Metric Latest value YoY change
NetIncomeLoss YoY -81%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 45,103,899 +11%
Common Stock, Shares, Outstanding 44,956,238 +12%
Common Stock, Value, Issued $5,000 +25%
Weighted Average Number of Shares Outstanding, Basic 44,917,032 +12%
Weighted Average Number of Shares Outstanding, Diluted 44,917,032 +12%

Additional Metrics

Metric Latest value YoY change
Research and Development Expense $40,919,000 +74%
General and Administrative Expense $25,379,000 +28%
Operating Income (Loss) $66,298,000 -53%
Nonoperating Income (Expense) $12,851,000 -5.9%
Earnings Per Share, Basic 1 +65%
Earnings Per Share, Diluted 1 +65%
Cash and Cash Equivalents, at Carrying Value $271,611,000 +3.3%
Assets, Current $275,997,000 +3.9%
Property, Plant and Equipment, Net $117,000 -25%
Operating Lease, Right-of-Use Asset $2,845,000 -21%
Other Assets, Noncurrent $414,000 -43%
Assets $279,836,000 +3.4%
Accounts Payable, Current $2,683,000 +184%
Liabilities, Current $5,102,000 +27%
Operating Lease, Liability, Noncurrent $2,113,000 -30%
Liabilities $7,215,000 +2.8%
Retained Earnings (Accumulated Deficit) $175,523,000 -44%
Stockholders' Equity Attributable to Parent $272,621,000 +3.5%
Liabilities and Equity $279,836,000 +3.4%
Share-based Payment Arrangement, Noncash Expense $3,270,000 +47%
Net Cash Provided by (Used in) Operating Activities $13,477,000 -114%
Net Cash Provided by (Used in) Financing Activities $35,000 -29%
Net Cash Provided by (Used in) Investing Activities $0
Common Stock, Shares Authorized 500,000,000 0%
Common Stock, Shares, Issued 44,956,238 +12%
Common Stock, Par or Stated Value Per Share 0 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $13,442,000 -115%
Operating Lease, Liability $3,002,000 -20%
Depreciation $13,000 +8.3%
Payments to Acquire Property, Plant, and Equipment $0
Lessee, Operating Lease, Liability, to be Paid $3,480,000 -24%
Property, Plant and Equipment, Gross $214,000 +4.9%
Operating Lease, Liability, Current $889,000 +15%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,207,000 +2.6%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,176,000 +2.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $478,000 -42%
Lessee, Operating Lease, Liability, to be Paid, Year Three $238,000 -80%
Preferred Stock, Shares Issued 0
Additional Paid in Capital $448,139,000 +16%
Preferred Stock, Shares Outstanding 0
Share-based Payment Arrangement, Expense $12,133,000 +33%
Preferred Stock, Par or Stated Value Per Share 0 0%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY